Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Adjuvanted vs Non-Adjuvanted H1N1 Vaccine in Children and Adults
NCT00973700Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2009
- Primary completion
- Oct 2009
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza A/H1N1 (H1N1), sponsored by Novartis. Started Aug 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza A/H1N1 (H1N1)
Beyond the preview
Go deeper on NCT00973700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973700.